Panna Sharma | President, Chief Executive Officer |
David Margrave | Chief Financial Officer |
Dr. Kerry Barnhart | Vice President of Clinical Development |
Marek Ciszewski | Investor Relations |
John Vandermosten | Zacks SCR |
Kayla Hostetler | Colliers Securities |
Daniel Carlson | TW Research Group |
Steve Popovich | Builders Inc. |
Good afternoon and welcome to Lantern Pharma’s First Quarter 2021 Conference Call.
As a reminder, this call is being recorded and all participants are in listen-only mode.
We will open the call for questions-and-answers after the presentation. I would now like to introduce your host for today's conference, Marek Ciszewski with Investor Relations at Lantern Pharma. Marek, please go ahead.